Ipratropium/Salbutamol Neutec

Ipratropium bromide, the active ingredient in Ipratropium/Salbutamol Neutec, is a bronchodilator (anticholinergic and β2‑agonist) presented as an inhalation aerosol (metered‑dose inhaler) for inhalation use. It treats asthma, chronic obstructive pulmonary disease (COPD) and acute bronchospasm in adults and children as prescribed.

GNH USA supplies Ipratropium/Salbutamol Neutec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and specialist respiratory centres worldwide.

Ipratropium/Salbutamol acts on the respiratory airways to relieve bronchoconstriction in several chronic and acute conditions. - Asthma: improves bronchodilation and symptom control during exacerbations. - Chronic obstructive pulmonary disease (COPD): reduces bronchospasm and enhances airflow in stable disease. - Acute bronchospasm: provides rapid relief of airway constriction during sudden attacks.

Common Side Effects: - Dry mouth - Throat irritation - Cough - Tremor - Headache - Palpitations

Serious or Rare Side Effects: - Paradoxical bronchospasm - Angioedema - Severe tachycardia or arrhythmia - Hypersensitivity reactions (rash, urticaria) - Significant hypertension - Anaphylactic shock

Before using Ipratropium/Salbutamol, consider the following precautions: - Cardiac history: monitor for tachycardia or arrhythmias. - Glaucoma or urinary retention: anticholinergic effects may exacerbate these conditions. - Severe COPD exacerbations: use with caution and under medical supervision. - Known hypersensitivity: avoid if allergic to any component of the inhaler. - Dosage limits: do not exceed the prescribed number of puffs. - Store at room temperature: keep in the original container, protect from moisture and heat.

Ipratropium/Salbutamol may interact with other medicines as follows: Major Interactions (Avoid): - Non‑selective β‑blockers: may diminish bronchodilator effect. - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: may increase anticholinergic side effects. Moderate Interactions (Monitor Closely): - Theophylline: may raise risk of tachyarrhythmia. - Diuretics: can exacerbate hypokalemia. - ACE inhibitors: may increase incidence of cough.